Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[Oral antidiabetic agents: recent aspects].

U Keller, W Berger

    Schweizerische Medizinische Wochenschrift
    |April 30, 1983
    PubMed
    Summary
    This summary is machine-generated.

    Sulfonylureas are potent oral antidiabetic drugs, potentially improving insulin sensitivity. However, their extrapancreatic effects are secondary to pancreatic stimulation, and they may cause hypoglycemia, especially newer generations.

    Related Concept Videos

    You might also read

    Related Articles

    Articles linked to this work by shared authors, journal, and citation graph.

    Sort by
    Same author

    Tightly locked optical frequency comb from a semiconductor disk laser.

    Optics express·2019
    Same author

    Programmable pulse shaping for time-gated amplifiers.

    Optics express·2019
    Same author

    Sub-150-fs pulses from an optically pumped broadband modelocked integrated external-cavity surface emitting laser.

    Optics letters·2019
    Same author

    High-power OPCPA generating 1.7 cycle pulses at 2.5 µm.

    Optics express·2018
    Same author

    Orientation-dependent stereo Wigner time delay and electron localization in a small molecule.

    Science (New York, N.Y.)·2018
    Same author

    Gas-lens effect in kW-class thin-disk lasers.

    Optics express·2018

    Area of Science:

    • Endocrinology
    • Pharmacology
    • Metabolic Diseases

    Background:

    • Sulfonylureas are widely prescribed oral antidiabetic agents.
    • Despite cardiovascular concerns from the UGDP study, their use persists due to new findings on their mechanism of action.

    Purpose of the Study:

    • To explore the extrapancreatic effects of sulfonylureas, particularly their influence on insulin sensitivity.
    • To investigate the relationship between pancreatic and extrapancreatic effects of sulfonylureas.
    • To compare the side effect profiles and risks of first- and second-generation sulfonylureas.

    Main Methods:

    • Review of existing literature on sulfonylurea mechanisms and clinical trials.
    • Analysis of studies investigating sulfonylureas' impact on insulin sensitivity in type II and type I diabetics.

    Related Experiment Videos

  • Comparison of adverse event profiles, including cardiovascular risks and hypoglycemia, between different sulfonylurea generations.

    • Main Results:

    • Sulfonylureas may enhance insulin sensitivity in type II diabetics by increasing insulin receptors, but this effect is dependent on simultaneous insulin secretion.
    • The extrapancreatic effects of sulfonylureas appear secondary to their pancreatic stimulation.
    • Sulfonylureas did not improve insulin sensitivity or reduce insulin requirements in type I diabetics.
    • Second-generation sulfonylureas are more potent and longer-acting, increasing hypoglycemia risk, while first-generation agents have more side effects and drug interactions.

    Conclusions:

    • The primary antidiabetic action of sulfonylureas involves stimulating insulin release.
    • Extrapancreatic effects on insulin sensitivity are secondary and context-dependent.
    • Careful consideration of side effect profiles and hypoglycemia risk is necessary when prescribing sulfonylureas, particularly newer generations.